Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Cash Flow Reinvestment Rate
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Cash Flow Reinvestment Rate of 0.77x as of September 2024, reinvesting CN¥39.75 Million (capex CN¥19.88 Million plus investments CN¥-19.87 Million) from operating cash flow of CN¥51.50 Million. See how much free cash does Jiangsu Lianhuan Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Jiangsu Lianhuan Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see 600513 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year capital reinvestment analysis for Jiangsu Lianhuan Pharmaceutical Co Ltd. See 600513 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 17.17x | CN¥184.85 Million | CN¥10.77 Million | CN¥184.84 Million | ▲ +1217.5% |
| 2023 | 1.30x | CN¥209.42 Million | CN¥160.70 Million | CN¥200.66 Million | ▼ -61.3% |
| 2022 | 3.37x | CN¥429.70 Million | CN¥127.59 Million | CN¥209.02 Million | ▲ +175.7% |
| 2021 | 1.22x | CN¥168.98 Million | CN¥138.34 Million | CN¥168.92 Million | ▼ -35.6% |
| 2020 | 1.90x | CN¥174.25 Million | CN¥91.94 Million | CN¥174.18 Million | ▼ -92.5% |
| 2017 | 25.42x | CN¥92.44 Million | CN¥3.64 Million | CN¥48.64 Million | ▲ +1876.3% |
| 2016 | 1.29x | CN¥90.42 Million | CN¥70.28 Million | CN¥46.21 Million | ▲ +180.9% |
| 2015 | 0.46x | CN¥28.45 Million | CN¥62.12 Million | CN¥27.41 Million | ▲ +36.2% |
| 2014 | 0.34x | CN¥23.37 Million | CN¥69.50 Million | CN¥23.37 Million | ▼ -59.5% |
| 2013 | 0.83x | CN¥30.85 Million | CN¥37.17 Million | CN¥30.85 Million | ▲ +123.3% |
| 2012 | 0.37x | CN¥6.30 Million | CN¥16.94 Million | CN¥6.30 Million | ▼ -53.0% |
| 2011 | 0.79x | CN¥18.98 Million | CN¥24.00 Million | CN¥18.98 Million | ▼ -35.0% |
| 2010 | 1.22x | CN¥10.26 Million | CN¥8.43 Million | CN¥10.26 Million | ▲ +26.8% |
| 2009 | 0.96x | CN¥13.29 Million | CN¥13.83 Million | CN¥13.29 Million | ▼ -44.6% |
| 2008 | 1.73x | CN¥30.25 Million | CN¥17.44 Million | CN¥30.25 Million | ▼ -1.0% |
| 2007 | 1.75x | CN¥14.08 Million | CN¥8.03 Million | CN¥14.08 Million | ▼ -49.5% |
| 2006 | 3.47x | CN¥35.19 Million | CN¥10.14 Million | CN¥35.19 Million | ▲ +4.9% |
| 2005 | 3.31x | CN¥12.65 Million | CN¥3.82 Million | CN¥12.65 Million | ▲ +114.2% |
| 2004 | 1.54x | CN¥5.24 Million | CN¥3.39 Million | CN¥5.24 Million | ▲ +397.1% |
| 2002 | 0.31x | CN¥5.97 Million | CN¥19.22 Million | CN¥5.97 Million | — |